Avanos Medical Inc. (AVNS)

$22.58

up-down-arrow $-0.63 (-2.71%)

As on 07-Oct-2024 16:10 EDT

Avanos Medical Inc. (AVNS) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 22.47 High: 23.17
52 Week Range
Low: 17.24 High: 25.36
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market cap

    $1,069 Mln

  • P/E Ratio

    153.47

  • P/B Ratio

    0.87

  • Industry P/E

    88.55

  • Debt to Equity

    0.13

  • ROE

    0.63 %

  • ROCE

    --

  • Div. Yield

    --

  • Book Value

    --

  • EPS

    165658

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Avanos Medical (AVNS)
0.67 -4.81 16.87 18.28 -10.67 -9.02 --
BSE Sensex
12.20 -0.16 1.32 22.81 11.05 16.56 11.80
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 07-Oct-2024  |  #As on 26-Oct-2023
2023
2022
2021
2020
2019
2018
2017
Avanos Medical (AVNS)
-17.11 -21.95 -24.43 36.14 -24.76 -2.99 24.88
S&P Small-Cap 600
13.89 -17.42 25.27 9.57 20.86 -9.70 11.73
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91

Valuation Score

Stock
Peer Median
loading...

Growth & Efficiency

Stock
Peer Median
loading...

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Peer Comparison Comparison Details

search
search
search
search
    loading...

    Shareholding Pattern Detailed Holdings

    Other details More Details

    CEO & Director

    Mr. Joseph F. Woody

    Senior VP, CFO & Chief Transformation Officer

    Mr. Michael C. Greiner

    Headquarters

    Alpharetta, GA
    Edit peer-selector-edit
    loading...
    loading...

    Key Facts

    • Market cap market-cap-information $1,068.77 Mln
    • Revenue (TTM)revenue-information $682.40 Mln
    • Earnings (TTM) earning-information $-3.70 Mln
    • Cash date-information $92.20 Mln
    • Total Debt info $218.30 Mln
    • Insider's Holding 2.85%
    • Liquidity liquidity High
    • 52 Week range week-range $17.24 - 25.36
    • Shares outstanding share-outstanding 45,949,000
    • 10 Years Aggregate:

      CFO: $566.50 Mln

      EBITDA: $813.20 Mln

      Net Profit: $-300.70 Mln

    About The Company

    • IPO Date 21-Oct-2014
    • CEO & Director Mr. Joseph F. Woody
    • Senior VP, CFO & Chief Transformation Officer Mr. Michael C. Greiner
    • Listing key-listing NYSE: AVNS
    • Country United States
    • Headquarters headquarters Alpharetta, GA
    • Website website https://avanos.com
    • Business

      Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health...  products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.  Read more

    FAQs for Avanos Medical Inc. (AVNS)

    The total asset value of Avanos Medical Inc (AVNS) stood at $ 1,866 Mln as on 30-Jun-24

    The share price of Avanos Medical Inc (AVNS) is $22.58 (NYSE) as of 07-Oct-2024 16:10 EDT. Avanos Medical Inc (AVNS) has given a return of -10.67% in the last 3 years.

    Avanos Medical Inc (AVNS) has a market capitalisation of $ 1,069 Mln as on 04-Oct-2024. As per Value Research classification, it is a Small Cap company.

    The P/B ratio of Avanos Medical Inc (AVNS) is 0.87 times as on 04-Oct-2024, a 80% discount to its peers’ median range of 4.25 times.

    The P/E ratio of Avanos Medical Inc (AVNS) is 153.47 times as on 04-Oct-2024, a 73% premium to its peers’ median range of 88.55 times.

    Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
    Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
    Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
    Step 4. Search for the Avanos Medical Inc (AVNS) and enter the required number of quantities and click on buy to purchase the shares of Avanos Medical Inc (AVNS).

    Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

    The CEO & director of Mr. Joseph F. Woody. is Avanos Medical Inc (AVNS), and CFO & Sr. VP is Mr. Michael C. Greiner.

    There is no promoter pledging in Avanos Medical Inc (AVNS).

    Avanos Medical Inc. (AVNS) Ratios
    Return on equity(%)
    0.63
    Operating margin(%)
    7
    Net Margin(%)
    1.13
    Dividend yield(%)
    --

    No, TTM profit after tax of Avanos Medical Inc (AVNS) was $-4 Mln.